322 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
or investigations; the impact of any healthcare reform and legislation or regulatory action in the United States and international markets; increasing market
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
agreement (VPPA) HEALTH EQUITY & ACCESS TO HEALTHCARE BMS has distributed approximately $118.3M in grant funding to support programs and services ESG … Blue Shield of Massachusetts, Former Board Member of Kindred Healthcare, National Surgical Hospitals, Value Options, Pediatric Services of American
424B5
mou2ia4hy5izh
16 Feb 24
Prospectus supplement for primary offering
4:34pm
424B2
2r42i7n7s6u16cpc9e
13 Feb 24
Prospectus for primary offering
8:00am
8-K
EX-99.1
i0f985qtjyeanq 2fgq
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
f4ty9 8avc6ovjjjce4
25 Jan 24
Third party tender offer statement
8:13am
424B5
l4s5o
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
xlcxec mmxquyn3
30 Oct 23
Prospectus supplement
8:05am
8-K
EX-99.1
lj26us
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
clablvat v9i7zz
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
EX-99.1
ka7b ia4yctlc8s727r9
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
DEFA14A
mwm pvyyebe0b
10 Apr 23
Additional proxy soliciting materials
5:12pm